Cargando…

Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020

The novel clinical data for plasma cell neoplasms (smoldering myeloma, multiple myeloma, and AL amyloidosis) that were presented in the 2020 American Society of Clinical Oncology virtual scientific symposium are summarized here. Data from large phase-3 studies (CASSIOPEIA, ENDURANCE, and TOURMALINE-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devarakonda, Srinivas, Cottini, Francesca, Bumma, Naresh, Khan, Abdullah, Sharma, Nidhi, Chaudhry, Maria, Benson, Don, Rosko, Ashley, Efebera, Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697517/ https://www.ncbi.nlm.nih.gov/pubmed/33187184 http://dx.doi.org/10.3390/jcm9113626

Ejemplares similares

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
por: Cottini, Francesca, et al.
Publicado: (2021)

Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience
por: Nunnelee, Jordan, et al.
Publicado: (2022)

Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma
por: Nunnelee, Jordan, et al.
Publicado: (2022)

Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma
por: Khan, Abdullah M., et al.
Publicado: (2023)

Racial differences as predictors of outcomes in young patients with multiple myeloma
por: Bao, Alicia, et al.
Publicado: (2022)

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
por: Bao, Alicia, et al.
Publicado: (2023)

Role of Stem Cell Transplantation in Multiple Myeloma
por: Devarakonda, Srinivas, et al.
Publicado: (2021)

AL Amyloidosis: The Effect of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
por: Ozga, Michael, et al.
Publicado: (2020)

AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival
por: Ozga, Michael, et al.
Publicado: (2020)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
por: Sharma, Nidhi, et al.
Publicado: (2021)

Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant
por: Sigmund, Audrey M., et al.
Publicado: (2022)

Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation
por: Sharma, Nidhi, et al.
Publicado: (2021)

To be or not to be: the role of CD56 in multiple myeloma
por: Cottini, Francesca, et al.
Publicado: (2023)

Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
por: Braunstein, Zachary, et al.
Publicado: (2022)

Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma
por: Ozga, Michael, et al.
Publicado: (2023)

Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Almaani, Salem, et al.
Publicado: (2021)

26th Annual Scientific Meeting of the Clinical Oncological Society of Australia
Publicado: (1999)

Multidisciplinary amyloidosis care in the era of personalized medicine
por: Bumma, Naresh, et al.
Publicado: (2022)

Minimal residual disease in multiple myeloma: are we there yet?
por: Devarakonda, Srinivas, et al.
Publicado: (2020)

Multidisciplinary Approach to Older Adults with Hematologic Malignancies—a Paradigm Shift
por: Wall, Sarah A., et al.
Publicado: (2022)

Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2020
Publicado: (2021)

Coexisting multiple myeloma, lymphoma, and non-small cell lung cancer: a case report and review of the literature
por: Khade, Parth, et al.
Publicado: (2017)

Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer Therapy
por: Sharma, Nidhi, et al.
Publicado: (2023)

Commentary on 19(th) annual scientific meeting of the Society for Neuro-Oncology
por: Jalali, Rakesh
Publicado: (2015)

Abstract Book: Society of Surgical Oncology 69(th) Annual Cancer Symposium
Publicado: (2016)

The Report of ASNC-JSNC Joint Symposium in JSNC 33(rd) Annual Scientific Meeting
por: Kiso, Keisuke
Publicado: (2023)

Meeting report from the 2020 Annual (virtual) Meeting of the American Society of Clinical Oncology
por: Salani, Ritu, et al.
Publicado: (2020)

Seventh BHD international symposium: recent scientific and clinical advancement
por: Woodford, Mark R., et al.
Publicado: (2022)

58th Annual Symposium of the International Society for Clinical Electrophysiology of Vision (ISCEV 2020): 14–16 September 2020
Publicado: (2020)

Transitioning to Virtual: ACMT’s 2020 Annual Scientific Meeting
por: Kopec, Kathryn T., et al.
Publicado: (2020)

Irish Thoracic Society Annual Scientific Meeting 2020
Publicado: (2021)

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022)

Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium: latest scientific and clinical discoveries
por: Bratslavsky, Gennady, et al.
Publicado: (2016)

Annual Scientific Conference
por: Pönisch, G, et al.
Publicado: (1993)

Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016
por: Alsayegh, Mohammad A., et al.
Publicado: (2017)

Annual Symposium in Electronics Packaging
por: Morris, James
Publicado: (1991)

Annual Reliability and Maintainability Symposium
por: Collective
Publicado: (2002)

10th Annual Symposium
por: Grünberger, Fred
Publicado: (1974)

Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology
por: Wolford, Juliet E., et al.
Publicado: (2017)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma
por: Jaglowski, Samantha M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s0pqk0r2r7in773ikloegsairq